Previous close | 0.4000 |
Open | N/A |
Bid | 0.0000 |
Ask | 4.8000 |
Strike | 140.00 |
Expiry date | 2024-10-18 |
Day's range | 0.4000 - 0.4000 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Westlake's (WLK) action builds on the company's commitment to contributing to a more sustainable future through continual development of its own manufacturing as well as strategic investments.
BD (BDX) announces the commercial launch of its new single-cell research tool, BD Rhapsody ATAC-Seq Assay, to help researchers understand DNA regulation.
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.